| 000 | 01556 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514030533.0 | ||
| 264 | 0 | _c20020416 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/01.res.0000014227.76102.5d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKiosses, William B | |
| 245 | 0 | 0 |
_aA dominant-negative p65 PAK peptide inhibits angiogenesis. _h[electronic resource] |
| 260 |
_bCirculation research _cApr 2002 |
||
| 300 |
_a697-702 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aGene Products, tat _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aOncogene Proteins _xphysiology |
| 650 | 0 | 4 |
_aPeptides _xgenetics |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xphysiology |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xpharmacology |
| 650 | 0 | 4 | _ap21-Activated Kinases |
| 700 | 1 | _aHood, John | |
| 700 | 1 | _aYang, Suya | |
| 700 | 1 | _aGerritsen, Mary E | |
| 700 | 1 | _aCheresh, David A | |
| 700 | 1 | _aAlderson, Nazilla | |
| 700 | 1 | _aSchwartz, Martin Alexander | |
| 773 | 0 |
_tCirculation research _gvol. 90 _gno. 6 _gp. 697-702 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.res.0000014227.76102.5d _zAvailable from publisher's website |
| 999 |
_c11838961 _d11838961 |
||